Evaluation of Variable Pressure Support Ventilation in the Therapy of Acute Lung Injury
NCT ID: NCT00786292
Last Updated: 2012-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2009-07-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Noisy PSV
Assisted mechanical ventilation with noisy PSV
Assisted mechanical ventilation
Patients will be mechanically ventilated with noisy PSV and PSV in random sequence
PSV
Assisted mechanical ventilation with PSV
Assisted mechanical ventilation
Patients will be mechanically ventilated with noisy PSV and PSV in random sequence
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assisted mechanical ventilation
Patients will be mechanically ventilated with noisy PSV and PSV in random sequence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 150 mmHg \< PaO2/FIO2 \< 300 mmHg
* mechanical ventilation with PSV or BIPAP
* less than 15 days of mechanical ventilation
* at least 20% of minute ventilation originated from spontaneous breathing
Exclusion Criteria
* esophageal disease
* neuromuscular disease
* instable thorax
* pneumothorax
* head trauma
* brain injury
* increased intracranial pressure
* agitation
* increased need for vasoactive drugs
* chronic lung disease
* acute coronary disease
* participation in another clinical trial within the last 4 weeks at enrollment
Interruption criteria:
* acute change of mental status
* SaO2 \< 92%
* pHa \< 7.30
* respiratory rate \> 30 or \< 6 /min
* dyspnea
* diaphragm/thorax antagonism
* diaphoresis
* abnormal use of respiratory muscles
* increase of the heart rate above 120% of baseline or absolute value \< 60 or \> 130 /min
* mean arterial pressure above 120% of baseline or absolute value \< 70 or \> 110 mmHg
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
PD Dr. Marcelo Gama de Abreu
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcelo Gama de Abreu, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Anesthesiology, University Clinic Carl Gustav Carus, Technical University Dresden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Clinic Carl Gustav Carus, Technical University Dresden
Dresden, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Spieth PM, Guldner A, Huhle R, Beda A, Bluth T, Schreiter D, Ragaller M, Gottschlich B, Kiss T, Jaber S, Pelosi P, Koch T, Gama de Abreu M. Short-term effects of noisy pressure support ventilation in patients with acute hypoxemic respiratory failure. Crit Care. 2013 Oct 31;17(5):R261. doi: 10.1186/cc13091.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK276112007
Identifier Type: -
Identifier Source: org_study_id